 CAMBRIDGE, Mass., May 5, 2021 PRNewswire -- Blueprint Medicines Corporation NASDAQ: BPMC today announced that, effective on May 1, 2021, the Compensation Committee of Blueprint Medicines Board of Directors granted non-qualified stock options to purchase an aggregate of 21,045 shares of its common stock and an aggregate of 10,520 restricted stock units RSUs to 13 new employees under Blueprint Medicines 2020 Inducement Plan. 